BillionToOne Inc., a molecular diagnostics company, raised $273.1 million in an upsized US initial public offering, during a US government shutdown that has complicated the listing process.
Molecular diagnostics firm BillionToOne raised $273.1 million in its U.S. initial public offering on Wednesday, pricing its shares above its marketed range.
Aggression and self-harm often co-occur in individuals with a history of early-life trauma-a connection that has largely been documented by self-reporting in research and clinical settings.
Guest writer Dr Kun-Yu Wang describes how the development of a tunable MOF illustrates chemistry's potential in mechanical ...
Plastic isn't just everywhere - it's everything. From the food we buy to the cars we drive, the global plastics economy is worth more than $800 billion. But its future hinges on one critical shift: ...
According to Mordor Intelligence, the global companion diagnostics market is valued at USD 8.70 billion in 2025 and is projected to surpass ...
According to Mordor Intelligence, the global companion diagnostics market is valued at USD 8.70 billion in 2025 and is ...
Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people worldwide.
The Global Point-of-Care Molecular Diagnostics Market is projected to grow at a CAGR of 10.2% from 2026 to 2033, according to a new report published by Verified Market Reports®. The report reveals ...
To make the therapy safer and more adaptable, UChicago researchers developed a new “split” system called GA1CAR. This uses ...
PAMAF™ technology delivers near-complete ion utilization, enabling deeper proteome coverage and improved PTM and proteoform analysis ...
Technology could be used to detect subtle shifts in bodily markers in breath that herald infections and cancers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback